HIGHLIGHTS
- who: Shasha Guan from the University of Salerno, Italy have published the Article: Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma, in the Journal: (JOURNAL) of 25/04/2022
- what: This study evaluated circulating tumor (ctDNA) for prognosis prediction and disease monitoring in metastatic pancreatic adenocarcinoma (PAC). The aim of this study was to determine the clinical value of ctDNA as a predictive biomarker in patients with metastatic pancreatic cancer. In the study , a panel of 425 genes was conducted.
- how: The results showed that positive KRAS mutation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.